Antibody Development

At Abpro, we develop custom antibodies that work in your hands and end applications.  Our team of experts will collaborate with you to design an antigen, immunization strategy, and screening workflow to meet your needs. We produce antibodies that work in your end application, whether it be routine screening, PK/PD studies, immunohistochemistry, western blot, flow cytometry or custom functional assays.

Abpro offers a comprehensive suite of antibody services, from gene synthesis to assay development.  We have a broad range of options available to meet all of your antibody needs.

Monoclonal Antibody Development

We leverage our DiversImmuneTM platform to generate antibodies that will work in your hands. Our platform is faster and more powerful, offering more diversity against previously difficult targets. We optimize for success starting from the beginning with powerful bioinformatics via our BiomaxTM system, then should antigen be required, our RaptorTM system, is massively parallel and allows high-speed generation, and then our ImmunomaxTM system generates large panels of antibodies for your selection. This is followed by our AffinimaxTM platform that optimizes for affinity.

The end result is that you’ll be working with one of the most powerful antibody development systems in the world to optimize for success.

Our platform has been well proven via literature and industry leaders. It is particularly well-suited for traditionally difficult targets and where speed is critical. These can include the following:

  • Single-amino acid differences
  • GPCRs
  • Anti-idiotypic mabs
  • Conformationally specific epitopes
  • High homology targets (human, rat or mouse)
  • Small molecules
  • Bi-specific antibodies
  • Antibody drug conjugates
  • Biosimilars
  • Biobetters

Our platform has been successful in generating mabs against every major application, ranging from research, to diagnostics, animal health and therapeutics.